The inhibition of PLK1 kinase selectively kills cancer cells by affecting their mitosis, leading to the up-regulation of PD-L1 expression in surviving cancer cells for a more effective PD-L1 antibody attack [107]. This evidence concerns the gene CD274 and cancer.